Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactobacillus brevis is a probiotic bacterium that has been investigated for its potential benefits in gastrointestinal health, including the management of constipation in children. The use of L. brevis for constipation is primarily supported by emerging scientific evidence rather than a strong tradition of historical use. Several clinical trials and animal studies have explored the effectiveness of various Lactobacillus species in relieving constipation, with some research specifically examining L. brevis. A few small-scale studies have shown that certain strains of L. brevis can improve bowel movement frequency and stool consistency, likely by modulating gut microbiota and enhancing intestinal motility. The mechanisms proposed include the production of short-chain fatty acids and the promotion of a healthier gut environment, which may facilitate regular bowel movements. However, the evidence is not robust: most studies involve small sample sizes, short durations, and sometimes use L. brevis as part of a multi-strain probiotic rather than as a single agent, making it difficult to isolate its specific effects. Overall, while there is some scientific rationale and preliminary evidence for the use of L. brevis in treating constipation in children, the quality and quantity of evidence remain limited. Larger, well-designed clinical trials are needed to establish its efficacy and safety more definitively. As such, its use might be considered as an adjunct to other therapies under medical supervision, but it should not replace established treatments.

More about Lactobacillus brevis
More about Constipation (children)

Other ingredients used for Constipation (children)

Other health conditions supported by Lactobacillus brevis

Products containing Lactobacillus brevis

Douglas Laboratories Multi-Probiotic ® 40 Billion
Douglas Laboratories Multi-Probiotic ® 40 Billion